Running Head: GENERALIZED ANXIETY DISORDER 1
GENERALIZED ANXIETY DISORDER 6
Generalized Anxiety Disorder
Student name
Professor
Course
Date of submission
Patient case analysis
Based on the case attached, the Patient exhibits a score history of suffering from a cognitive-based illness. From the examination processes that have been identified, there is a great importance of narrowing done in a solving mechanism. The analysis highlighted in the third case gives the additional advantage of choosing the three effective processes that can be used to handle the case. For instance, at his age, having a feeling that was suspected to be a heart attack and related shortage in breathing is a clear indication that a cognitive-based intervention was a consideration. Cases of hypertension as well create the basis of having the tenure of choosing from the three approaches (Alexander Bystritsky, 2019). In this case, there are professional; methods that can be put in place to handle the condition. This would more prevent continuity and initialize healing ad recovering processes. These models are supported by the Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-5).
Decision one Zoloft 50 Mg orally daily
The first approach application is using Zoloft, which applied orally ion a daily basis. It’s one of the best practice approaches that can be used to considering the Patient’s condition as it was examined in the case. Amongst the signs that the Patient has exhibited include stress and related pain that was becoming hard to manage. Besides that, it has integrated panic disorder, which is closely associated with heart and hypertension Melinda Smith. (2019). additionally, the Patient was taking three to four bottles of beer, which is a condition that will exist in may include patients.
In this case, this method would play a significant role in handling the case and responding to the Patient’s condition in about 86%. Sertraline has been proved to treat depression and panic attacks as well as a compulsive disorder. It s a form of psychotropic medication, and therefore useful in the treatment of anxiety disorder that has been exhibited (Amy Morin, LCSW, 2019). Besides that, Choosing this model was based on facts; it was associated with a lot of scientific proof and in the treatment process as well as addressing the adverse effects of panic and attacks. In case the analysis depicts that the case had extended such the cognitive limits, dispensation would be a consideration to step in.
Consequently, Sertralines has defined selective serotonin reuptake inhibitor (SSRI), which should be administered as directed by the physician. The inhibitor factor is the science and hope behind choosing this approach and medical intervention. The good thing about the application of this medicine is the balanced scorecard; it can be used with or without food in both forms of tablets and liquids.
When Zoloft 50 Mg approach has been applied, the primary expectation is to have a defined process that will help in restoring the balance of a particular natural substance (serotonin) that is present in the brain (Healthline Editorial Team, 2019). The result of the process has a Functional restore process and patients that enable the Patient to recover, especially in his judgment. The gradual level of the model consists of chemical structure processes, and principal assessor, which show progress from the stage of recovering to another.
Decision 2 – Increase dose to 75 mg orally daily
In this case, the Patient should continue with the medication but gradually take 75 Mg. The factor behind this decision is to continue with the prescribed medication since symptoms are showing a positive response to the drugs. An examination of the Patient revealed that the symptoms of anxiety reduced by 50% after the Patient followed the prescription. Additionally, the Patient is also not experiencing an adverse reaction to the drugs prescribed; hence, the decision was well evaluated. HAM-A side effects and the effect the drug has had on the Patient’s anxiety has drastically reduced. The decision, however, depends on the Patient’s response and predictable factors as the treatment processes.
When making the prescription, I was hoping that the drugs would not have side effects on the Patient since finding the right medication that is safe and effective for anxiety patients is difficult and often takes time. Drugs often react with each other to cause unpredictable side effects. I, therefore, expected that the prescribed drugs would negatively affect the Patient. Also, I was hoping that the Patient was not taking other medication before I made the prescription as they would increase the chances of adverse reactions to the prescribed drugs (Alexander Bystritsky, 2019). Moreover, I was hoping that the drug would improve the anxiety levels of the Patient significantly to know whether the Patient would continue with the medication or not.
I expected an adverse reaction to the medication, which often occurs to anxiety patients. On the contrary, the Patient did not seem to have any side effects of the drug after using it for a short period. Also, I did not expect such an improvement in patient anxiety symptoms after using drugs. The Patient’s symptoms had reduced by more than 50%. On the contrary, I expected more significant improvement since the drugs effects are unpredictable and more so at an additional of 25Mg.
Decision point three- Three Maintain current dose
In this stage, the decision was to maintain the current dose. This factor would be used to evaluate clinical objectives that have been achieved after the utilization of a gradual dosage approach. Maintaining the dose was a delicate process of gaining if any other intervention would be introduced on the same note stabilizing the drug administration would reduce the side effects of the Patient considering his age. It was a clear indication that the Patient was on the recovering processes. The balanced scorecard also demonstrated the necessity of increasing the 25 Mg in the second decision point. The hope and the reason behind taking decisions are winning the cognitive aspect and schedules of anxiety recovery processes (Alexander Bystritsky, 2019). The objective of decision three had a 100% percent recovery. Nevertheless, there was only a 50% reduction in the system. Nevertheless, the Patient was in the best road approving attaining the high transaction rate.
Ethical in professionalism
For a medical intervention to be effectively put in place, it’s always necessary to handle its high and profiled model. Besides, it’s the processes used by the corporate organization to attain sustainable and compelling competitive advantage. The ethical aspect plays a significant role in enhancing communications and between involved parties. It influences individuals to put in place work ethics and organizational culture at the forefront. On a broader scope and professional setup enables satisfying Patient will in the medication processes (Bill Wargin, Ph.D., 2020). Every stakeholder, in this case, is incorporated as part and parcel of the healing processes. It encourages confidentiality between the Patient and the medical officer. This includes making data private and available upon request. It’s a very crucial tool in the working environment. It prevents errors and commands effective management since ethics is the social norms of a working set up.
References
Alexander Bystritsky. (2019). Current diagnosis and treatment of anxiety disorders. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628173/
Amy Morin, LCSW. (2019). The best types of therapy to treat anxiety. Retrieved from https://www.verywellmind.com/anxiety-therapy-4692759
Bill Wargin, Ph.D. (2020, March 16). Treatments for anxiety disorders. Retrieved from https://www.blackdoginstitute.org.au/resources-support/anxiety/treatment/
The Healthline Editorial Team. (2019). Drugs to treat anxiety disorder. Retrieved from https://www.healthline.com/health/anxiety-drugs#antidepressants
Melinda Smith. (2019). Therapy for anxiety disorders. Retrieved from https://www.helpguide.org/articles/anxiety/therapy-for-anxiety-disorders.htm
